Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Naples, Italy as a location and removed Napoli, Italy from the study locations.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded Hepatocellular carcinoma keyword and Genetic and Rare Diseases Information Center resource. Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check25 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. The visible study details and layout remain unchanged.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded site revision label 'Revision: v3.4.2'; removed the prior operational notice and revision 'Revision: v3.4.1' related to government funding and operating status.SummaryDifference0.2%

- Check61 days agoChange DetectedNotice about government funding lapse is added at the top of the page, and a new PubMed publication citation related to the study is included. Page revision identifiers updated from v3.4.0 to v3.4.1; to avoid alerts for small changes, set an alert condition.SummaryDifference0.2%

- Check68 days agoChange DetectedAdministrative updates to the page, including Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.